Havn Life Sciences Inc (HAVN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 10-2021 | 07-2021 | 04-2021 | 01-2021 | 10-2020 | |
| Sales | 28 | 9 | 0 | 0 | 0 |
| Cost of Goods | 16 | 5 | N/A | N/A | N/A |
| Gross Profit | 12 | 4 | N/A | N/A | N/A |
| Operating Expenses | 3,155 | 2,970 | 10,442 | 7,680 | 5,399 |
| Operating Income | -3,143 | -2,966 | -10,442 | -7,680 | -5,399 |
| Interest Expense | 16 | 17 | N/A | N/A | 1 |
| Other Income | -2,758 | 12 | -557 | -5,480 | -5 |
| Pre-tax Income | -5,917 | -2,971 | -10,999 | -13,160 | -5,404 |
| Net Income Continuous | -5,917 | -2,971 | -10,999 | -13,160 | -5,404 |
| Net Income | $-5,917 | $-2,971 | $-10,999 | $-13,160 | $-5,404 |
| EPS Basic Total Ops | -1.50 | -0.90 | -3.07 | -5.10 | -3.30 |
| EPS Basic Continuous Ops | -1.50 | -0.90 | -3.07 | -5.10 | -3.30 |
| EPS Diluted Total Ops | -1.50 | -0.90 | -3.07 | -5.10 | -3.30 |
| EPS Diluted Continuous Ops | -1.50 | -0.90 | -3.07 | -5.10 | -3.30 |
| EBITDA(a) | $-5,754 | $-2,823 | $-13,732 | $-6,521 | $-4,685 |